Skip to content

Organon OGN Total Equity

Total Equity at other companies

Pfizer logo
PfizerPFE
$90.1B-0.3%
Amgen logo
AmgenAMGN
$9.19B+48.1%
The Cooper Companies, Inc. logo
The Cooper Companies, Inc.COO
$8.24B-0.6%
AbbVie logo
AbbVieABBV
-$6.66B-569%
Amneal Pharmaceuticals, Inc. logo
Amneal Pharmaceuticals, Inc.AMRX
-$45.41M+65.5%
Biogen logo
BiogenBIIB

Other financials

Income statement

See full
Revenue$1.5B-3.5%
Gross profit$783.0M-6.9%
Net income$146.0M+67.8%
EPS (diluted)$0.55+66.7%

Balance sheet

See full
Cash & equivalents$1.1B+104%
Total debt$8.6B-4.3%
Total assets$13.0B-1.2%

Cash flow

See full
Operating cash flow$225.0M+200%
CapEx$37.0M+15.6%
Free cash flow$188.0M+337%

Valuation

See full
Market cap$3.53B-59.4%
Enterprise value$10.98B-26.4%
P/E6.6×+2.1×
P/S0.6×-0.8×

Profitability

See full
Gross margin52.8%-4.4pp
Net margin8%-12.3pp
FCF margin11.1%-1.3pp

Returns & leverage

See full
Return on equity71.6%
Debt / equity9.5×-7.0×
Current ratio+0.3×

Where this comes from

Reported directly by Organon in its filing.

Tagged under the XBRL concept us-gaap:StockholdersEquity.

The official record: Organon’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about Organon's total equity.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Organon's total equity?
Organon (OGN) reported total equity of $903M in Q1 2026.
How has Organon's total equity changed year-over-year?
Organon's total equity increased by 66.6% year-over-year, from $542M to $903M.
What is the long-term trend for Organon's total equity?
Over 5 years (2020 to 2025), Organon's total equity has grown at a -32.8% compound annual growth rate (CAGR), from $5.49B to $752M.
What does total equity mean?
Net assets attributable to shareholders — total assets minus total liabilities. Represents the book value of shareholders' ownership claim.